Numerous neurodegenerative diseases, such as neuroinflammation, which includes multiple sclerosis, Parkinson’s and Alzheimer’s disease, and neuropsychiatric disorders, may be influenced by caffeine’s potential to antagonize the A2A subtype of adenosine receptors (A2AAR). This evidence concerns the gene IGKV2D-29 and Alzheimer disease.